Yue He1, Liang Xu1, Bo Li1, Zhen-Ni Guo1, Qin Hu1, Zongduo Guo1, Junjia Tang1, Yujie Chen1, Yang Zhang1, Jiping Tang1, John H Zhang2. 1. From the Departments of Anesthesiology and Basic Sciences, Loma Linda University School of Medicine, CA (Y.H., L.X., B.L., Z-N.G., Q.H., Z.G., Junjia Tang, Y.C., Y.Z., Jiping Tang, J.H.Z.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, PR China (Y.H.); Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China (L.X., J.T.); Department of Neurosurgery, Jinan General Military Hospital, Jinan, PR China (B.L.); and Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, PR China (Y.C.). 2. From the Departments of Anesthesiology and Basic Sciences, Loma Linda University School of Medicine, CA (Y.H., L.X., B.L., Z-N.G., Q.H., Z.G., Junjia Tang, Y.C., Y.Z., Jiping Tang, J.H.Z.); Department of Neurosurgery, Tong-ji Hospital, Wuhan, PR China (Y.H.); Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China (L.X., J.T.); Department of Neurosurgery, Jinan General Military Hospital, Jinan, PR China (B.L.); and Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, PR China (Y.C.). johnzhang3910@yahoo.com.
Abstract
BACKGROUND AND PURPOSE: Macrophage-inducible C-type lectin (Mincle, CLEC4E) receptor is reported involved in neuroinflammation in cerebral ischemia and traumatic brain injury. This study was designed to investigate the role of Mincle and its downstream spleen tyrosine kinase (Syk) signal pathway in early brain injury after subarachnoid hemorrhage (SAH) in a rat model. METHODS: Two hundred fifteen male Sprague-Dawley rats (280-320 g) were subjected to endovascular perforation model of SAH. SAH grade, neurological score, and brain water content were measured at 24 hours after SAH. Mincle/Syk, as well as CARD9 (a member of the caspase-associated recruitment domain [CARD], involved in innate immune response), interleukin-1β,and myeloperoxidase expressions were analyzed by Western blot at 24 hours after SAH. Specific cell types that expressed Mincle were detected with double immunofluorescence staining. Mincle small interfering RNA, recombinant SAP130, and a selective Syk phosphorylation inhibitor piceatannol were used for intervention. RESULTS: Brain water content increased and neurological functions decreased in rats after SAH. The expression of SAP130, Mincle, Syk, and p-Syk increased at 12 hours and peaked at 24 hours after SAH. Mincle small interfering RNA reduced interleukin-1β and infiltration of myeloperoxidase positive cells, decreased brain water content, and improved neurological functions at 24 hours after SAH. Recombinant SAP130 upregulated the expression of p-Syk and CARD9 and increased the levels of interleukin-1β and myeloperoxidase, even though it did not increase brain water content nor it deteriorated neurological function at 24 hours after SAH. Syk inhibitor piceatannol reduced brain edema at 24 hours after SAH. CONCLUSION: Mincle/Syk is involved in early brain injury after SAH, and they may serve as new targets for therapeutic intervention.
BACKGROUND AND PURPOSE:Macrophage-inducible C-type lectin (Mincle, CLEC4E) receptor is reported involved in neuroinflammation in cerebral ischemia and traumatic brain injury. This study was designed to investigate the role of Mincle and its downstream spleen tyrosine kinase (Syk) signal pathway in early brain injury after subarachnoid hemorrhage (SAH) in a rat model. METHODS: Two hundred fifteen male Sprague-Dawley rats (280-320 g) were subjected to endovascular perforation model of SAH. SAH grade, neurological score, and brain water content were measured at 24 hours after SAH. Mincle/Syk, as well as CARD9 (a member of the caspase-associated recruitment domain [CARD], involved in innate immune response), interleukin-1β,and myeloperoxidase expressions were analyzed by Western blot at 24 hours after SAH. Specific cell types that expressed Mincle were detected with double immunofluorescence staining. Mincle small interfering RNA, recombinant SAP130, and a selective Syk phosphorylation inhibitor piceatannol were used for intervention. RESULTS: Brain water content increased and neurological functions decreased in rats after SAH. The expression of SAP130, Mincle, Syk, and p-Syk increased at 12 hours and peaked at 24 hours after SAH. Mincle small interfering RNA reduced interleukin-1β and infiltration of myeloperoxidase positive cells, decreased brain water content, and improved neurological functions at 24 hours after SAH. Recombinant SAP130 upregulated the expression of p-Syk and CARD9 and increased the levels of interleukin-1β and myeloperoxidase, even though it did not increase brain water content nor it deteriorated neurological function at 24 hours after SAH. Syk inhibitor piceatannol reduced brain edema at 24 hours after SAH. CONCLUSION:Mincle/Syk is involved in early brain injury after SAH, and they may serve as new targets for therapeutic intervention.
Authors: J A Frontera; L Aledort; E Gordon; N Egorova; H Moyle; A Patel; J B Bederson; F Sehba Journal: J Thromb Haemost Date: 2012-04 Impact factor: 5.824
Authors: Alba Jimenez-Pacheco; Guillaume Mesuret; Amaya Sanz-Rodriguez; Katsuhiro Tanaka; Claire Mooney; Ronan Conroy; Maria Teresa Miras-Portugal; Miguel Diaz-Hernandez; David C Henshall; Tobias Engel Journal: Epilepsia Date: 2013-06-28 Impact factor: 5.864
Authors: Omer Nuri Pamuk; Peter H Lapchak; Poonam Rani; Polly Pine; Jurandir J Dalle Lucca; George C Tsokos Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-06-03 Impact factor: 4.052
Authors: Juan Carlos de Rivero Vaccari; Frank J Brand; Aldo F Berti; Ofelia F Alonso; M Ross Bullock; Juan Pablo de Rivero Vaccari Journal: J Neurotrauma Date: 2014-12-10 Impact factor: 5.269
Authors: Christine A Wells; Judith A Salvage-Jones; Xin Li; Kelly Hitchens; Suzanne Butcher; Rachael Z Murray; Anthony G Beckhouse; Yu-Lan-Sandra Lo; Silvia Manzanero; Christian Cobbold; Kate Schroder; Bo Ma; Sally Orr; Lauren Stewart; Daniel Lebus; Peter Sobieszczuk; David A Hume; Jennifer Stow; Helen Blanchard; Robert B Ashman Journal: J Immunol Date: 2008-06-01 Impact factor: 5.422
Authors: Alexey V Kostarnoy; Petya G Gancheva; Bernd Lepenies; Amir I Tukhvatulin; Alina S Dzharullaeva; Nikita B Polyakov; Daniil A Grumov; Daria A Egorova; Andrey Y Kulibin; Maxim A Bobrov; Ekaterina A Malolina; Pavel A Zykin; Andrey I Soloviev; Evgeniy Riabenko; Diana V Maltseva; Dmitry A Sakharov; Alexander G Tonevitsky; Lyudmila V Verkhovskaya; Denis Y Logunov; Boris S Naroditsky; Alexander L Gintsburg Journal: Proc Natl Acad Sci U S A Date: 2017-03-14 Impact factor: 11.205
Authors: Stephanie H Greco; Alejandro Torres-Hernandez; Aleksandr Kalabin; Clint Whiteman; Rae Rokosh; Sushma Ravirala; Atsuo Ochi; Johana Gutierrez; Muhammad Atif Salyana; Vishnu R Mani; Savitha V Nagaraj; Michael Deutsch; Lena Seifert; Donnele Daley; Rocky Barilla; Mautin Hundeyin; Yuriy Nikifrov; Karla Tejada; Bruce E Gelb; Steven C Katz; George Miller Journal: J Immunol Date: 2016-08-24 Impact factor: 5.422